Related by context. Frequent words. (Click for all words.) 86 Phase 1b clinical 81 phase IIa 81 Phase Ib 80 Phase IIa clinical 79 Phase Ia 79 Phase 2a clinical 79 phase IIb 79 Phase 1b 78 Phase 1b trial 78 Phase 2b study 77 Phase IIb clinical 77 Phase 2a 77 Phase IIa 76 Phase 2b trial 76 Phase 2a trial 76 Phase 2b clinical 76 Phase III clinical 76 Phase 1a 75 Phase IIa trial 75 phase 2a 75 Phase IIb 74 dose escalation trial 74 Phase III 73 Phase IIb trial 73 Phase 2b 72 confirmatory Phase III 72 Phase II 72 pivotal Phase III 71 randomized Phase III 71 multicenter clinical 71 dose escalation study 70 tesmilifene 69 clinical trial 69 Phase III clinical trials 69 multiple ascending dose 68 CA4P 68 PXD# 68 randomized Phase 67 BAY #-# 67 Phase III pivotal 67 HGS ETR1 67 single ascending dose 67 Phase III trials 67 multicenter randomized double 66 TELCYTA 66 eltrombopag 66 teduglutide 66 MLN# 66 preclinical 66 IMGN# 66 relapsing remitting multiple sclerosis 66 TG# [001] 66 diabetic neuropathic pain 66 MOZOBIL 66 pivotal Phase 66 vicriviroc 66 dose cohorts 65 pharmacokinetic studies 65 relapsed multiple myeloma 65 dose escalation 65 tolerability 65 nitazoxanide 65 preclinical studies 65 randomized controlled clinical 65 pharmacokinetic 65 HspE7 65 CYT# 65 ASA# 65 OXi# 65 orally bioavailable 65 MDV# 65 clinical trials 65 Phase III Trial 65 placebo controlled 65 BCX# 65 ZYBRESTAT 65 PEG Interferon lambda 64 CoFactor 64 pharmacodynamics 64 randomized placebo controlled 64 RG# [001] 64 Perifosine 64 methylnaltrexone 64 investigational compound 64 PROMACTA 64 PF # [001] 64 PS# [001] 64 ISIS # 64 HuMax CD# 64 PRX # 64 decitabine 64 Phenoptin 64 blinded placebo controlled 64 DB# [003] 64 safety tolerability pharmacokinetics 64 AACR NCI EORTC 64 confirmatory Phase 3 64 carfilzomib 64 double blind placebo 64 imetelstat 64 CTCE